21 January 2016 To:

advertisement
21 January 2016
To:
ISPE Members and Staff
From: Michael A. Arnold, 2015-2016 Vice-Chair, ISPE International Board of Directors
Re:
Nominations for 2016-2018 International Board of Directors
As Chair of the Board Nominating Committee, I am asking for your help to identify colleagues within ISPE who
would be well-suited to serve on the ISPE International Board of Directors.
The International Board of Directors is responsible for the governance and strategic direction of our Society.
Members of the Board are people who know our Society, understand our industry and have strong strategic
leadership capabilities. Potential candidates should have most, if not all, of the following characteristics:









They must be strategic thinkers. The Board is responsible for the Society's long-term planning.
They must be willing to be Ambassadors and communicate on behalf of the Society.
They should be leaders. While we would hope that they are leaders within the Society, evidence of
leadership in business or another professional organization is desirable.
They need financial acumen. The Board oversees a budget in excess of US $10 million.
They need "business sense." ISPE is not-for-profit, however we still must bring in ample money to
achieve our goals.
They must understand the current and future needs and strategies of manufacturers and service
providers in the global pharma/biopharma industry, advancing science, technology and engineering in a
highly regulated environment.
They must be able to commit to spending time working on ISPE issues, and they must be able to travel
to four Board meetings per year.
They must be ISPE Members; any nominee who is not currently an ISPE Member will be required to join
the Society before being placed on the ballot.
They must be fluent in English. Board meetings are conducted in English, and Members need to be able
to understand and communicate in that language.
In an effort to represent a global view of our industry and to ensure organizational success, it is important we
have an appropriately diverse International Board of Directors. Diversity is represented in many ways; examples
may include business expertise, gender, geographic location and young professionals. If you know of someone
who fits the above description and can expand our Board diversity, I encourage you to reach out to them,
confirm their willingness to be considered, and send a completed Nomination Form along with the nominee's
curriculum vitae or resume to nominations@ispe.org by 26 February 2016. Self-nominations are also welcome.
Thank you for your help with this critical task for ISPE.
Best regards,
Michael A. Arnold
2015-2016 Vice Chair, ISPE International Board of Directors
2016 Nominating Committee Chair
7200 Wisconsin Ave., Suite 305, Bethesda, MD 20814 USA
T 1 301-364-9201 F 1 240-204-6024 ispe.org
Connecting
Pharmaceutical
Knowledge
Download